Study Calls For Action On Heart Risks From Certain Anti-cancer Drugs

Heart damage from certain anti-cancer drugs no longer should be regarded as a rare or relatively unimportant complication, scientists have concluded in a new overview of research on the cardiotoxicity of anti-cancer drugs. Their review recommends that drug regulatory agencies, physicians, and toxicologists join in a focused research effort to combat the problem.